Sveriges mest populära poddar
To the Point
VetenskapTeknologi

Considerations for Use of Two Newly Approved Drugs

31 min•11 oktober 2023
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.

Fler avsnitt av To the Point

Visa alla avsnitt av To the Point
The Intersection of Dry Eye and Allergies
•33 min
Continuing the Dry Eye Conversation
•37 min
A Year of Dry Eye Innovation
•25 min
Clinical Pearls for Autologous Serum Drops
•31 min
Aesthetics and the Ocular Surface
•29 min
Running a Standalone Dry Eye Clinic
•34 min
Building Out a Dry Eye and Aesthetics Practice
•45 min
Takeways From the TFOS DEWS III Report
•30 min
A Lesson in Blink Mechanics and Dry Eye
•30 min
Is it Dry Eye or Corneal Pathology?
•34 min

To the Point med Modern Optometry finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.